Cargando…

Intraarticular Administration of Dexamethasone after Mesenchymal Stem Cells Implantation Does Not Improve Significantly the Treatment of Preestablished Full-Thickness Chondral Defect in a Rabbit Model

OBJECTIVE: The aim of this study was to evaluate the contribution to hyaline cartilage regeneration of dexamethasone intraarticular administration after autologous mesenchymal stem cells (MSCs) implantation into a preestablished knee full-thickness chondral defect. DESIGN: Full-thickness chondral de...

Descripción completa

Detalles Bibliográficos
Autores principales: Espinosa, Maximiliano, Vaisman, Alex, Nazal, Nicolas, Figueroa, David, Gallegos, Marcela, Conget, Paulette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297101/
https://www.ncbi.nlm.nih.gov/pubmed/26069657
http://dx.doi.org/10.1177/1947603512472696
_version_ 1782353103450800128
author Espinosa, Maximiliano
Vaisman, Alex
Nazal, Nicolas
Figueroa, David
Gallegos, Marcela
Conget, Paulette
author_facet Espinosa, Maximiliano
Vaisman, Alex
Nazal, Nicolas
Figueroa, David
Gallegos, Marcela
Conget, Paulette
author_sort Espinosa, Maximiliano
collection PubMed
description OBJECTIVE: The aim of this study was to evaluate the contribution to hyaline cartilage regeneration of dexamethasone intraarticular administration after autologous mesenchymal stem cells (MSCs) implantation into a preestablished knee full-thickness chondral defect. DESIGN: Full-thickness chondral defects of 4.5 × 4.5 mm(2) were surgically made in both medial femoral condyles of adult male New Zealand rabbits. Two weeks later, autologous ex vivo expanded bone marrow–derived MSCs were embedded in hyaluronic acid and implanted into the chondral defects. Immediately and every week after the intervention, dexamethasone 0.25 mg/kg was intraarticularly administered (MSC/dexa-treated group). Six weeks after MSC transplantation, the animals were euthanized and condyles were characterized molecularly according to aggrecan, collagen type II, and collagen type I gene expression (quantitative reverse transcriptase-polymerase chain reaction) and histologically (hematoxylin–eosin staining). Data of MSC/dexa-treated condyles were compared with untreated, dexa-treated, MSC-treated, or normal unlesioned condyles. RESULTS: The ratio between collagen type II expression versus collagen type I expression in MSC/dexa-treated condyles was higher than one, even though the group mean value was not statistically different from that of untreated defects. Histological changes were observed between MSC/dexa-treated and untreated defects mainly in surface regularity and in hyaline matrix abundance. However, International Cartilage Repair Society score analysis did not support robust differences between those groups. CONCLUSION: Intraarticular administration of dexamethasone after autologous MSC implantation into a preestablished full-thickness chondral defect does not contribute significantly to the regeneration of a tissue with molecular and histological characteristics identical to hyaline cartilage.
format Online
Article
Text
id pubmed-4297101
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-42971012015-06-11 Intraarticular Administration of Dexamethasone after Mesenchymal Stem Cells Implantation Does Not Improve Significantly the Treatment of Preestablished Full-Thickness Chondral Defect in a Rabbit Model Espinosa, Maximiliano Vaisman, Alex Nazal, Nicolas Figueroa, David Gallegos, Marcela Conget, Paulette Cartilage Article OBJECTIVE: The aim of this study was to evaluate the contribution to hyaline cartilage regeneration of dexamethasone intraarticular administration after autologous mesenchymal stem cells (MSCs) implantation into a preestablished knee full-thickness chondral defect. DESIGN: Full-thickness chondral defects of 4.5 × 4.5 mm(2) were surgically made in both medial femoral condyles of adult male New Zealand rabbits. Two weeks later, autologous ex vivo expanded bone marrow–derived MSCs were embedded in hyaluronic acid and implanted into the chondral defects. Immediately and every week after the intervention, dexamethasone 0.25 mg/kg was intraarticularly administered (MSC/dexa-treated group). Six weeks after MSC transplantation, the animals were euthanized and condyles were characterized molecularly according to aggrecan, collagen type II, and collagen type I gene expression (quantitative reverse transcriptase-polymerase chain reaction) and histologically (hematoxylin–eosin staining). Data of MSC/dexa-treated condyles were compared with untreated, dexa-treated, MSC-treated, or normal unlesioned condyles. RESULTS: The ratio between collagen type II expression versus collagen type I expression in MSC/dexa-treated condyles was higher than one, even though the group mean value was not statistically different from that of untreated defects. Histological changes were observed between MSC/dexa-treated and untreated defects mainly in surface regularity and in hyaline matrix abundance. However, International Cartilage Repair Society score analysis did not support robust differences between those groups. CONCLUSION: Intraarticular administration of dexamethasone after autologous MSC implantation into a preestablished full-thickness chondral defect does not contribute significantly to the regeneration of a tissue with molecular and histological characteristics identical to hyaline cartilage. SAGE Publications 2013-04 /pmc/articles/PMC4297101/ /pubmed/26069657 http://dx.doi.org/10.1177/1947603512472696 Text en © The Author(s) 2013
spellingShingle Article
Espinosa, Maximiliano
Vaisman, Alex
Nazal, Nicolas
Figueroa, David
Gallegos, Marcela
Conget, Paulette
Intraarticular Administration of Dexamethasone after Mesenchymal Stem Cells Implantation Does Not Improve Significantly the Treatment of Preestablished Full-Thickness Chondral Defect in a Rabbit Model
title Intraarticular Administration of Dexamethasone after Mesenchymal Stem Cells Implantation Does Not Improve Significantly the Treatment of Preestablished Full-Thickness Chondral Defect in a Rabbit Model
title_full Intraarticular Administration of Dexamethasone after Mesenchymal Stem Cells Implantation Does Not Improve Significantly the Treatment of Preestablished Full-Thickness Chondral Defect in a Rabbit Model
title_fullStr Intraarticular Administration of Dexamethasone after Mesenchymal Stem Cells Implantation Does Not Improve Significantly the Treatment of Preestablished Full-Thickness Chondral Defect in a Rabbit Model
title_full_unstemmed Intraarticular Administration of Dexamethasone after Mesenchymal Stem Cells Implantation Does Not Improve Significantly the Treatment of Preestablished Full-Thickness Chondral Defect in a Rabbit Model
title_short Intraarticular Administration of Dexamethasone after Mesenchymal Stem Cells Implantation Does Not Improve Significantly the Treatment of Preestablished Full-Thickness Chondral Defect in a Rabbit Model
title_sort intraarticular administration of dexamethasone after mesenchymal stem cells implantation does not improve significantly the treatment of preestablished full-thickness chondral defect in a rabbit model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297101/
https://www.ncbi.nlm.nih.gov/pubmed/26069657
http://dx.doi.org/10.1177/1947603512472696
work_keys_str_mv AT espinosamaximiliano intraarticularadministrationofdexamethasoneaftermesenchymalstemcellsimplantationdoesnotimprovesignificantlythetreatmentofpreestablishedfullthicknesschondraldefectinarabbitmodel
AT vaismanalex intraarticularadministrationofdexamethasoneaftermesenchymalstemcellsimplantationdoesnotimprovesignificantlythetreatmentofpreestablishedfullthicknesschondraldefectinarabbitmodel
AT nazalnicolas intraarticularadministrationofdexamethasoneaftermesenchymalstemcellsimplantationdoesnotimprovesignificantlythetreatmentofpreestablishedfullthicknesschondraldefectinarabbitmodel
AT figueroadavid intraarticularadministrationofdexamethasoneaftermesenchymalstemcellsimplantationdoesnotimprovesignificantlythetreatmentofpreestablishedfullthicknesschondraldefectinarabbitmodel
AT gallegosmarcela intraarticularadministrationofdexamethasoneaftermesenchymalstemcellsimplantationdoesnotimprovesignificantlythetreatmentofpreestablishedfullthicknesschondraldefectinarabbitmodel
AT congetpaulette intraarticularadministrationofdexamethasoneaftermesenchymalstemcellsimplantationdoesnotimprovesignificantlythetreatmentofpreestablishedfullthicknesschondraldefectinarabbitmodel